Skip to main content
. 2017 Sep 30;12(3):169–174. doi: 10.5114/pg.2017.70468
B
Variable Remicade® (n = 28) Inflectra® (n = 55) P-value
Exacerbation 75% 21 64% 34 0.64
Repeated biological treatment 21% 6 17% 9 0.83
Exacerbation < 6 months 67% 14 62% 21 0.86
Referral for colectomy 25% 7 23% 12 0.90